UY33002A - Proceso para la preparación de calcobutrol - Google Patents

Proceso para la preparación de calcobutrol

Info

Publication number
UY33002A
UY33002A UY0001033002A UY33002A UY33002A UY 33002 A UY33002 A UY 33002A UY 0001033002 A UY0001033002 A UY 0001033002A UY 33002 A UY33002 A UY 33002A UY 33002 A UY33002 A UY 33002A
Authority
UY
Uruguay
Prior art keywords
calcobutrol
preparation process
complex
preparation
traazacyclodecano
Prior art date
Application number
UY0001033002A
Other languages
English (en)
Inventor
Dr Johannes Platzek
Dr Wilhelm Trentmann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43297060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY33002(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY33002A publication Critical patent/UY33002A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/04—Calcium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Proceso para la preparación del complejo con calcio del ácido 10-(2,3-Dihidoxi-1-(hidroximetil)propil)-1, 4,7, 10-te-traazaciclodecano-1, 4, 7-triacético, que también se conoce como Calcobutrol, comenzando a partir del complejo con gadolinio (Gadobutrol) puro. Además, Calcobutrol con un nivel de pureza desconocido hasta el presente.
UY0001033002A 2009-11-04 2010-11-04 Proceso para la preparación de calcobutrol UY33002A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009053171A DE102009053171B4 (de) 2009-11-04 2009-11-04 Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol)

Publications (1)

Publication Number Publication Date
UY33002A true UY33002A (es) 2011-06-30

Family

ID=43297060

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033002A UY33002A (es) 2009-11-04 2010-11-04 Proceso para la preparación de calcobutrol

Country Status (35)

Country Link
US (1) US9447053B2 (es)
EP (2) EP2599777A1 (es)
JP (1) JP5733800B2 (es)
KR (3) KR101057939B1 (es)
CN (1) CN102164901B (es)
AR (1) AR078906A1 (es)
AU (1) AU2010317166C1 (es)
BR (1) BR112012010320B1 (es)
CA (1) CA2777314C (es)
CL (1) CL2012001172A1 (es)
CO (1) CO6551758A2 (es)
CR (1) CR20120235A (es)
CU (1) CU24105B1 (es)
CY (1) CY1115051T1 (es)
DE (1) DE102009053171B4 (es)
DK (1) DK2496562T3 (es)
DO (1) DOP2012000126A (es)
EA (2) EA020161B9 (es)
EC (1) ECSP12011866A (es)
ES (1) ES2462970T3 (es)
HK (1) HK1161237A1 (es)
HR (1) HRP20140399T1 (es)
IL (1) IL219012A0 (es)
MX (1) MX2012005283A (es)
MY (1) MY158421A (es)
NZ (2) NZ599705A (es)
PE (1) PE20130224A1 (es)
PL (1) PL2496562T3 (es)
PT (1) PT2496562E (es)
RS (1) RS53287B (es)
SI (1) SI2496562T1 (es)
TW (1) TWI473794B (es)
UY (1) UY33002A (es)
WO (1) WO2011054827A1 (es)
ZA (1) ZA201202504B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2896405T (lt) 2011-04-21 2020-03-25 Bayer Intellectual Property Gmbh Didelio grynumo gadobutrolio gamyba
EP2786768A1 (en) 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
KR101693400B1 (ko) * 2014-09-17 2017-01-05 에스티팜 주식회사 칼코부트롤의 제조방법
KR101646211B1 (ko) * 2014-11-12 2016-08-05 (주)디아이테크 자기공명영상용 조영제의 제조방법
CN105037288B (zh) * 2015-07-23 2017-11-03 上海现代制药海门有限公司 一种布醇的制备方法
CN106620726B (zh) * 2015-10-29 2020-10-02 山东威智百科药业有限公司 一种钆布醇注射液及其制备方法
CN106187930B (zh) * 2016-07-12 2018-10-19 嘉实（湖南）医药科技有限公司 高纯度考布曲钙的制备方法
PL3519394T3 (pl) 2016-09-27 2020-11-30 Bayer Pharma Aktiengesellschaft Sposób wytwarzania krystalicznej postaci o modyfikacji a kalkobutrolu
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
CN109384737A (zh) * 2017-08-04 2019-02-26 天津科伦药物研究有限公司 一种四氮杂环钇络合物及其制备方法和应用
KR101971435B1 (ko) * 2017-08-29 2019-04-24 주식회사 엔지켐생명과학 가도부트롤 중간체 및 이를 이용한 가도부트롤의 제조 방법
KR20190088793A (ko) * 2018-01-19 2019-07-29 주식회사 엔지켐생명과학 칼코부트롤의 제조방법
WO2020012372A1 (en) 2018-07-10 2020-01-16 Biophore India Pharmaceuticals Pvt. Ltd Process for the preparation of 2,2',2''-(10-((2r,3s)-1,3,4-trihydroxy butan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid and its complexes
WO2020084504A1 (en) * 2018-10-24 2020-04-30 Biophore India Pharmaceuticals Pvt. Ltd Novel process for the preparation of macrocyclic chelant 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetra azacyclododecane-1,4,7-triyl) triacetic acid and it's complexes with paramagnetic metal ions
MX2021006024A (es) * 2018-11-23 2021-07-06 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos.
KR101979836B1 (ko) * 2019-01-02 2019-05-21 동국생명과학 주식회사 칼코부트롤의 제조방법
CN111039885B (zh) * 2019-12-06 2021-03-05 广州康瑞泰药业有限公司 一种制备高纯度考布曲钙的方法
CN114845990A (zh) 2019-12-20 2022-08-02 伯拉考成像股份公司 钙bopta配合物
KR20210112910A (ko) 2020-03-06 2021-09-15 주식회사 엔지켐생명과학 가도부트롤 주사제 제조를 위한 부형제인 칼코부트롤의 제조 방법
KR20210114742A (ko) * 2020-03-11 2021-09-24 주식회사 엔지켐생명과학 칼테리돌의 제조방법
CN114573522A (zh) * 2020-11-30 2022-06-03 江苏恒瑞医药股份有限公司 一种考布曲钙的新晶型及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625417C2 (de) 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
DE3640708C2 (de) * 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4009119A1 (de) 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
IE910955A1 (en) 1990-03-23 1991-09-25 Yamanouchi Europ Bv Il-6 inhibiting compositions
DE4237943C2 (de) * 1992-11-06 1997-10-23 Schering Ag Verfahren zur Herstellung von Metallkomplexen der N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- und N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivate
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
IT1275426B (it) * 1995-05-16 1997-08-07 Bracco Spa Recupero del gadolinio e dei suoi agenti complessanti da soluzioni acquose contenenti i loro complessi
DE19724186C2 (de) 1997-06-02 2002-07-18 Schering Ag Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe
IT1292130B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione dell'acido 1,4,7,10-tetraazaciclododecan -1,4,7-triacetico e suoi derivati
IT1293778B1 (it) 1997-07-25 1999-03-10 Bracco Spa 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
US9016221B2 (en) * 2004-02-17 2015-04-28 University Of Florida Research Foundation, Inc. Surface topographies for non-toxic bioadhesion control
WO2011054480A1 (de) * 2009-11-09 2011-05-12 Bayer Schering Pharma Aktiengesellschaft Gadobutrolherstellung mittels keramischer membran

Also Published As

Publication number Publication date
CA2777314A1 (en) 2011-05-12
DE102009053171B4 (de) 2011-07-21
NZ599705A (en) 2014-03-28
NZ612449A (en) 2015-01-30
AU2010317166B2 (en) 2014-11-27
EP2496562A1 (en) 2012-09-12
AR078906A1 (es) 2011-12-14
JP2013510117A (ja) 2013-03-21
CL2012001172A1 (es) 2012-09-14
KR20120093388A (ko) 2012-08-22
ECSP12011866A (es) 2012-07-31
WO2011054827A1 (en) 2011-05-12
CN102164901A (zh) 2011-08-24
MX2012005283A (es) 2012-10-05
KR20110086885A (ko) 2011-08-01
EP2599777A1 (en) 2013-06-05
BR112012010320A2 (pt) 2016-03-29
AU2010317166C1 (en) 2019-02-28
ES2462970T3 (es) 2014-05-27
CR20120235A (es) 2012-08-01
EP2496562B1 (en) 2014-02-12
TWI473794B (zh) 2015-02-21
US20120309962A1 (en) 2012-12-06
TW201139387A (en) 2011-11-16
PL2496562T3 (pl) 2014-07-31
KR20110058746A (ko) 2011-06-01
US9447053B2 (en) 2016-09-20
DK2496562T3 (da) 2014-05-12
IL219012A0 (en) 2012-06-28
CN102164901B (zh) 2015-03-11
PE20130224A1 (es) 2013-03-06
RS53287B (en) 2014-08-29
HRP20140399T1 (hr) 2014-06-06
DE102009053171A1 (de) 2011-05-05
ZA201202504B (en) 2013-06-26
DOP2012000126A (es) 2012-08-15
MY158421A (en) 2016-10-14
CA2777314C (en) 2017-09-12
HK1161237A1 (en) 2012-08-24
SI2496562T1 (sl) 2014-06-30
JP5733800B2 (ja) 2015-06-10
CU20120072A7 (es) 2012-10-15
EA020161B9 (ru) 2018-11-30
BR112012010320B1 (pt) 2019-05-14
EA201300789A1 (ru) 2013-12-30
EA020161B1 (ru) 2014-09-30
CA2777314E (en) 2011-05-12
CU24105B1 (es) 2015-07-30
CO6551758A2 (es) 2012-10-31
KR101251210B1 (ko) 2013-04-08
CY1115051T1 (el) 2016-12-14
KR101057939B1 (ko) 2011-08-18
AU2010317166A1 (en) 2012-05-03
EA201200652A1 (ru) 2012-12-28
PT2496562E (pt) 2014-05-13

Similar Documents

Publication Publication Date Title
UY33002A (es) Proceso para la preparación de calcobutrol
CL2012000581A1 (es) Proceso para la preparacion de 1-cloro-4-(ß-d-glucopiranos-1-il)-2-[4-tetrahidrofuran-3-iloxi-bencil]-benceno con separacion de fases mediada por la adicion de acidos.
WO2010014524A3 (en) Soluble thread in the manufacture of footwear
EA201071058A1 (ru) Получение леналидомида
CO6511271A2 (es) Compuestos de imidazopiridinil-aminopiridina sustituida
CU24187B1 (es) Derivados sustituidos de imidazopiridazinas útiles para el tratamiento o profilaxis de trastornos hiperproliferativos y la angiogénesis
CR20120264A (es) Compuestos
BR112012006912A8 (pt) Hipervesiculação de cepas de shigella
AR061727A1 (es) Sintesis de dietil [[ 5- ( 3-fluorofenil) -piridin -2il] metil] fosfonato
CO6590210A1 (es) Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina
BR112012030360A2 (pt) cápsula de dose única para produzir uma bebida e método para produzir uma bebida
NZ593787A (en) Lyophilised dabigatran
BR112012027625A2 (pt) ligante para refratários monolíticos, refratário monolítico, e método de construção de refratários monolíticos
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
IN2014DN06964A (es)
MX2017015606A (es) Proceso para preparar 3-metilciclopentadecan-1,5-diona.
CL2008001513A1 (es) Uso de hidrofobinas como auxiliares en la cristalizacion de un solido; proceso para la produccion de un solido por cristalizacion a partir de una fase acuosa y separando el solido formado desder la fase acuosa.
BR112015014335A2 (pt) (6r,10r)-6,10,14-trimetilpentadecan-2-ona preparada a partir de 6,10-dimetilundec-5-en-2-ona ou 6,10-dimetilundeca-5,9-dien-2-ona
BR112016030604B8 (pt) Processo para preparação de ácidos 3- hidroxipicolínicos
UY30740A1 (es) Nuevo procedimiento para la preparacion de 4,4??-( 1-metil-1,2-etandilil)-bis-(2,6-piperazindiona)
CO6470817A2 (es) Cristales de solvato novedosos
BR112015007192A2 (pt) método para produção de ácido peracético de equilíbrio e ácido peracético de equilíbrio obtenível pelo método
CR20110208A (es) Proceso para la preparación de benzonorbornenos
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
NI200900154A (es) Nuevos procedimiento de obtención de la forma cristalina v de la agomelatina

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210804